TipRanks
Rockwell Medical Technologies (CH:RMTI)
:RMTI
Switzerland Market
RMTI
Rockwell Med
RESEARCH TOOLSreports

Rockwell Med (RMTI) Ratios

0 Followers

Rockwell Med Ratios

CH:RMTI's free cash flow for Q2 2026 was $0.18. For the 2026 fiscal year, CH:RMTI's free cash flow was decreased by $ and operating cash flow was $-0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.25 3.98 2.63 1.73 2.00
Quick Ratio
 3.00 3.63 2.22 1.38 1.67
Cash Ratio
 0.94 1.12 1.11 0.54 0.57
Solvency Ratio
 -0.16 -0.15 0.06 -0.23 -0.56
Operating Cash Flow Ratio
 0.26 -0.07 0.30 -0.57 -0.96
Short-Term Operating Cash Flow Coverage
 1.64 -2.50 15.68 -38.57 -7.93
Net Current Asset Value
$ 14.92M$ 18.00M$ 10.41M$ -2.11M$ 2.78M
Leverage Ratios
Debt-to-Assets Ratio
 0.25 0.22 0.23 0.26 0.35
Debt-to-Equity Ratio
 0.40 0.34 0.42 0.63 1.16
Debt-to-Capital Ratio
 0.28 0.25 0.29 0.39 0.54
Long-Term Debt-to-Capital Ratio
 0.17 0.19 0.21 0.28 0.35
Financial Leverage Ratio
 1.61 1.55 1.82 2.45 3.31
Debt Service Coverage Ratio
 -0.81 -1.44 1.94 -1.84 -3.97
Interest Coverage Ratio
 -3.99 -4.17 0.48 -2.90 -8.67
Debt to Market Cap
 0.27 0.30 0.14 0.19 0.97
Interest Debt Per Share
 3.81 3.78 4.76 0.67 1.85
Net Debt to EBITDA
 -1.46 -0.88 -0.72 -0.95 -0.39
Profitability Margins
Gross Profit Margin
17.71%16.89%17.23%10.41%5.60%
EBIT Margin
-5.69%-6.05%0.76%-7.34%-23.00%
EBITDA Margin
-3.37%-2.88%2.91%-5.61%-22.20%
Operating Profit Margin
-6.52%-6.77%0.60%-7.98%-23.05%
Pretax Profit Margin
-7.33%-7.67%-0.47%-10.09%-25.65%
Net Profit Margin
-7.33%-7.67%-0.47%-10.09%-25.65%
Continuous Operations Profit Margin
-7.33%-7.67%-0.47%-10.09%-25.65%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
112.40%113.28%-78.95%126.52%111.32%
Return on Assets (ROA)
-8.99%-9.30%-0.81%-16.18%-40.05%
Return on Equity (ROE)
-14.03%-14.37%-1.47%-39.64%-132.42%
Return on Capital Employed (ROCE)
-9.97%-9.86%1.35%-18.77%-57.97%
Return on Invested Capital (ROIC)
-9.23%-9.49%1.28%-17.68%-50.72%
Return on Tangible Assets
-11.00%-11.41%-1.00%-20.84%-40.86%
Earnings Yield
-15.34%-17.71%-0.76%-19.14%-187.44%
Efficiency Ratios
Receivables Turnover
 8.36 8.51 12.24 7.67 11.63
Payables Turnover
 17.96 28.80 29.28 16.59 16.96
Inventory Turnover
 20.27 16.81 14.54 12.76 11.82
Fixed Asset Turnover
 7.45 8.82 9.81 7.59 8.46
Asset Turnover
 1.23 1.21 1.71 1.60 1.56
Working Capital Turnover Ratio
 2.66 2.69 5.79 5.62 4.56
Cash Conversion Cycle
 41.37 51.95 42.46 54.19 40.73
Days of Sales Outstanding
 43.69 42.91 29.82 47.59 31.38
Days of Inventory Outstanding
 18.01 21.71 25.11 28.61 30.87
Days of Payables Outstanding
 20.32 12.68 12.47 22.00 21.52
Operating Cycle
 61.69 64.63 54.92 76.19 62.25
Cash Flow Ratios
Operating Cash Flow Per Share
 0.73 -0.18 1.35 -0.40 -1.72
Free Cash Flow Per Share
 0.39 -0.33 1.03 -0.42 -1.74
CapEx Per Share
 0.34 0.15 0.33 0.01 0.03
Free Cash Flow to Operating Cash Flow
 0.53 1.82 0.76 1.03 1.02
Dividend Paid and CapEx Coverage Ratio
 2.13 -1.22 4.16 -33.14 -60.25
Capital Expenditure Coverage Ratio
 2.13 -1.22 4.16 -33.14 -60.25
Operating Cash Flow Coverage Ratio
 0.21 -0.05 0.31 -0.70 -1.03
Operating Cash Flow to Sales Ratio
 0.04 >-0.01 0.04 -0.11 -0.23
Free Cash Flow Yield
4.66%-4.00%5.04%-22.00%-172.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -6.02 -5.56 -80.95 -5.22 -0.53
Price-to-Sales (P/S) Ratio
 0.48 0.43 0.62 0.53 0.14
Price-to-Book (P/B) Ratio
 0.94 0.81 1.94 2.07 0.71
Price-to-Free Cash Flow (P/FCF) Ratio
 21.45 -24.98 19.86 -4.55 -0.58
Price-to-Operating Cash Flow Ratio
 11.44 -45.53 15.08 -4.68 -0.59
Price-to-Earnings Growth (PEG) Ratio
 0.03 -0.01 0.87 0.06 0.01
Price-to-Fair Value
 0.94 0.81 1.94 2.07 0.71
Enterprise Value Multiple
 -15.58 -15.90 20.73 -10.34 -1.00
Enterprise Value
 36.45M 31.76M 61.23M 48.54M 16.23M
EV to EBITDA
 -15.58 -15.90 20.73 -10.34 -1.00
EV to Sales
 0.53 0.46 0.60 0.58 0.22
EV to Free Cash Flow
 23.67 -26.45 19.19 -5.01 -0.94
EV to Operating Cash Flow
 12.58 -48.20 14.57 -5.16 -0.96
Tangible Book Value Per Share
 6.26 7.34 6.91 0.41 1.34
Shareholders’ Equity Per Share
 8.86 10.28 10.49 0.91 1.43
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 17.53 19.25 32.68 3.58 7.38
Net Income Per Share
 -1.28 -1.48 -0.15 -0.36 -1.89
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.29 1.27 -0.62 1.37 1.12
Research & Development to Revenue
 <0.01 0.00 <0.01 0.01 0.04
SG&A to Revenue
 0.24 236.59 0.17 0.15 0.21
Stock-Based Compensation to Revenue
 0.03 0.03 0.01 0.01 <0.01
Income Quality
 -0.57 0.12 -8.75 1.12 0.91
Currency in USD